Key CGM Updates and Highlights from the EASD 2024 Conference | S3E3

Techniques for implementing CGM in primary care

In this episode, Dr. Jennifer Green dives into several sessions from the EASD 2024 meeting held in Madrid, Spain (September 9-13, 2024), covering topics on the impact of CGM use in T2D on hemoglobin A1C in patients using insulin and non-insulin therapies; hospitalization and ER rates; in non-ICU hospitalized patients; in hospitalized sub-populations of patients who had undergone cardiac surgery, and in sub-populations who had diabetic ketoacidosis. In addition, Dr. Green also covered the impact of hyperglycemia on one-year mortality in older patients using insulin, as well as a new glucose monitoring device that provides calibration-free intradermal glucose.

To learn more about the full program on CGM use in Primary Care and claim free CME Credits, visit https://diabetes-cgm.ime.springerhealthcare.com/

This program is made possible thanks to an independent educational grant from Abbott.

Intended for healthcare professionals only.

© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved. Published and licensed by Dove Medical Press Limited. Green J. Techniques for implementing continuous glucose monitoring in primary care: key CGM updates and highlights from the EASD 2024 Conference [Podcast]](https://www.dovepress.com/techniques-for-implementing-continuous-glucose-monitoring-in-primary-3-peer-reviewed-fulltext-article-DMSO)). Diabetes Metab Syndr Obes. 2024;17:4463–4468. doi:10.2147/DMSO.S503949 (CC BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc/4.0/)